Centyrin-targeted siRNA Conjugates for Extra-hepatic Delivery: ABX1100, a CD71 Centyrin-Gys1 siRNA Conjugate for Treatment of Pompe Disease
Conference Dates
April 4 - 8, 2024
Abstract
Please click Additional Files below to see the full abstract.
Recommended Citation
Sukumar Sakamuri, "Centyrin-targeted siRNA Conjugates for Extra-hepatic Delivery: ABX1100, a CD71 Centyrin-Gys1 siRNA Conjugate for Treatment of Pompe Disease" in "Delivery Of Nucleic Acid Therapeutics II: Biology, Engineering And Development", Steven F. Dowdy, UCSD School of Medicine, USA; Laura Sepp-Lorenzino, Intellia Therapeutics, USA; Matt Stanton, Generation Bio, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/nucleic_acid_therapeutics_ii/25
24.pdf (99 kB)
COinS